Home  >  Products  >  SLC6A3 (solute carrier family 6 (neurotransmitter transporter, dopamine), member 3) Blocking Peptide (the N terminal of SLC6A3)(100ug)
SLC6A3 (solute carrier family 6 (neurotransmitter transporter, dopamine), member 3) Blocking Peptide (the N terminal of SLC6A3)(100ug)

SLC6A3 (solute carrier family 6 (neurotransmitter transporter, dopamine), member 3) Blocking Peptide (the N terminal of SLC6A3)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-SLC6A3 Antibody(ARP43791_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP43791
Size: 100ug
Weight: 68kDa
Gene: 6531
Format: Lyophilized powder
Target: This gene encodes a dopamine transporter which is a member of the sodium- and chloride-dependent neurotransmitter transporter family. The 3' UTR of this gene contains a 40 bp tandem repeat, referred to as a variable number tandem repeat or VNTR, which can be present in 3 to 11 copies. Variation in the number of repeats is associated with idiopathic epilepsy, attention-deficit hyperactivity disorder, dependence on alcohol and cocaine, susceptibility to Parkinson disease and protection against nicotine dependence.
Alternative names: DAT; DAT1
See Full Product Listings >